Nicotinamide adenine dinucleotide production activator, sirt-1 activator, mitochondrial activator, gls-1 activity inhibitor, medicine, cosmetic, and food or beverage

WO2026140335A1PCT designated stage Publication Date: 2026-07-02JAPAN PHARMACEUTICAL MEDICINE CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
JAPAN PHARMACEUTICAL MEDICINE CO LTD
Filing Date
2025-08-04
Publication Date
2026-07-02

Smart Images

  • Figure JP2025027494_02072026_PF_FP_ABST
    Figure JP2025027494_02072026_PF_FP_ABST
Patent Text Reader

Abstract

The present invention comprises (i) or (ii). (i) Golden oyster mushroom or a processed product thereof. (ii) Nicotinamide mononucleotide and 5-deazaflavin.
Need to check novelty before this filing date? Find Prior Art